2024
Influenza Activity and Preterm Birth in the Atlanta Metropolitan Area: A Time-Series Analysis from 2010 to 2017
Zheng X, Wang T, Hao H, D’Souza R, Strickland M, Warren J, Darrow L, Chang H. Influenza Activity and Preterm Birth in the Atlanta Metropolitan Area: A Time-Series Analysis from 2010 to 2017. Epidemiology 2024, 36: 141-148. PMID: 39588975, PMCID: PMC11785485, DOI: 10.1097/ede.0000000000001819.Peer-Reviewed Original ResearchInfluenza-like illnessExposure lagTest positivityPreterm birthPregnant peopleRisk of adverse birth outcomesIncreased risk of adverse birth outcomesInfluenza activityAssociated with increased risk of preterm birthInterquartile range increaseAdverse birth outcomesTime-varying confoundersComposite measureRisk of preterm birthShort-term associationsAssociated with increased riskPublic health burdenPoisson log-linear modelSymptoms of influenza-like illnessEstimate associationsBirth outcomesEffect modificationAnnual influenza epidemicsRange increaseMaternal characteristicsA Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma
Hofmeister C, Gupta V, Kaufman J, Nooka A, Joseph N, Lonial S, Dhodapkar M. A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma. Blood 2024, 144: 255-255. DOI: 10.1182/blood-2024-202102.Peer-Reviewed Original ResearchPlasma cell disorderStandard armInfluenza vaccineMyeloma patientsIntensive armDaratumumab exposureRandomized Controlled TrialsMultiple myelomaFlu seasonCell disordersHistory of severe allergic reactionsStandard-dose influenza vaccinesTreat analysisRisk of influenza-like illnessT-cell engagersSeasonal influenza vaccineHigh dose vaccineHigh dose injectionsInfluenza-like illnessProportion of patientsFlu vaccinationVaccine preventable illnessYears of ageSevere allergic reactionsStatistically significant differenceEtranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
Coppens M, Pipe S, Miesbach W, Astermark J, Recht M, van der Valk P, Ewenstein B, Pinachyan K, Galante N, Le Quellec S, Monahan P, Leebeek F, Investigators H, Castaman G, Crary S, Escobar M, Gomez E, Haley K, Hermans C, Kampmann P, Kazmi R, Key N, Klamroth R, Konkle B, Kruse-Jarres R, Lattimore S, Lemons R, Meijer K, O'Connell N, Quon D, Raheja P, Symington E, Verhamme P, Visweshwar N, von Drygalski A, Wang M, Wheeler A, White S, Young G. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial. The Lancet Haematology 2024, 11: e265-e275. PMID: 38437857, DOI: 10.1016/s2352-3026(24)00006-1.Peer-Reviewed Original ResearchConceptsAnnualised bleeding rateLead-in periodFactor IX prophylaxisEtranacogene dezaparvovecPhase 3 trialGene therapyFactor IX activityAdverse eventsIX activityHemophilia BHemophilia B.Safety dataTreatment-related adverse eventsPost hoc efficacy analysisPost-hocTreatment-related deathsFactor IX expressionFull analysis setHemophilia B treatmentEffective therapeutic optionInfluenza-like illnessBleed protectionData cutoffBleeding phenotypePrimary endpoint
2023
The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China
Chang D, Lin M, Song N, Zhu Z, Gao J, Li S, Liu H, Liu D, Zhang Y, Sun W, Zhou X, Yang B, Li Y, Wang L, Xiao Z, Li K, Xing L, Xie L, Sharma L. The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China. Virology Journal 2023, 20: 189. PMID: 37620959, PMCID: PMC10463403, DOI: 10.1186/s12985-023-02115-x.Peer-Reviewed Original ResearchConceptsInfluenza BAverage ageCOVID-19Influenza-like illnessNumber of patientsMajor respiratory pathogenCOVID-19 testCOVID-19-related restrictionsCell death markersClinical characteristicsFever clinicYounger patientsAppropriate vaccinationPatient characteristicsSubstantial morbidityRespiratory virusesSeasonal virusesLaboratory findingsPositivity rateInfluenza ARespiratory pathogensPreventive strategiesSecondary infectionSevere casesFlu seasonMolecular characterisation of human adenoviruses associated with respiratory infections in Uganda
Ukuli Q, Erima B, Mubiru A, Atim G, Tugume T, Kibuuka H, Mworozi E, Ducatez M, Wabwire-Mangen F, Byarugaba D. Molecular characterisation of human adenoviruses associated with respiratory infections in Uganda. BMC Infectious Diseases 2023, 23: 435. PMID: 37370005, PMCID: PMC10294467, DOI: 10.1186/s12879-023-08403-9.Peer-Reviewed Original ResearchConceptsPolymerase chain reactionSpecies of human adenovirusHuman adenovirusDiverse group of virusesMultiple genetic variantsInfluenza-like illnessAdenovirus-vectored vaccineGroup of virusesGenome sequenceGenetic diversityAdenovirus-positiveHAdV infectionGenomic characterizationSequenced isolatesSpecies HAdV-BGenetic variantsRespiratory infectionsChildren Aged 5Hexon geneNasopharyngeal samplesGenotype B3Molecular characterisationTertiary hospitalUgandan populationCell linesFirst-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
Autio K, Higano C, Nordquist L, Appleman L, Zhang T, Zhu X, Babiker H, Vogelzang N, Prasad S, Schweizer M, Madan R, Billotte S, Cavazos N, Bogg O, Li R, Chan K, Cho H, Kaneda M, Wang I, Zheng J, Tang S, Hollingsworth R, Kern K, Petrylak D. First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC). Journal For ImmunoTherapy Of Cancer 2023, 11: e005702. PMID: 36948505, PMCID: PMC10040068, DOI: 10.1136/jitc-2022-005702.Peer-Reviewed Original ResearchConceptsMetastatic castration-resistant prostate cancerAndrogen deprivation therapyRadiographic progression-free survivalCastration-resistant prostate cancerPhase 1 studyBiochemical recurrenceProstate cancerImmunotherapy regimenMedian durationDose escalationMedian radiographic progression-free survivalAntigen-specific T cell responsesImmune-related adverse eventsRecommended phase 2 doseSpecific T cell responsesPhase 2 doseImmune checkpoint inhibitorsModest antitumor activityObjective response rateProgression-free survivalAntigen-specific immunityT cell responsesInfluenza-like illnessSignificant side effectsDeprivation therapy
2021
Diagnosis of dengue fever in a patient with early pregnancy loss
Adjei NN, Lynn AY, Topran E, Adeyemo OO. Diagnosis of dengue fever in a patient with early pregnancy loss. BMJ Case Reports 2021, 14: e243968. PMID: 34404662, PMCID: PMC8375744, DOI: 10.1136/bcr-2021-243968.Peer-Reviewed Original ResearchConceptsInfluenza-like illnessEarly pregnancy lossConsistent clinical evidenceHistory of travelMosquito-borne virusDengue-endemic areasAbdominal crampingDengue serologyOrbital painVaginal bleedingMultiparous womenPreterm birthWeeks' gestationNeonatal deathClinical evidenceIntravenous fluidsPregnant womenAdverse outcomesPregnancy lossDengue feverDengueFeverGestationMiscarriageWomen
2020
An aberration detection-based approach for sentinel syndromic surveillance of COVID-19 and other novel influenza-like illnesses
Wen A, Wang L, He H, Liu S, Fu S, Sohn S, Kugel J, Kaggal V, Huang M, Wang Y, Shen F, Fan J, Liu H. An aberration detection-based approach for sentinel syndromic surveillance of COVID-19 and other novel influenza-like illnesses. Journal Of Biomedical Informatics 2020, 113: 103660. PMID: 33321199, PMCID: PMC7832634, DOI: 10.1016/j.jbi.2020.103660.Peer-Reviewed Original ResearchConceptsInfluenza-like illnessFirst Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies
Pipe S, Recht M, Key N, Leebeek F, Castaman G, Lattimore S, Van Der Valk P, Peerlinck K, Coppens M, O'Connell N, Pasi J, Kampmann P, Meijer K, von Drygalski A, Young G, Hermans C, Astermark J, Klamroth R, Lemons R, Visweshwar N, Crary S, Kazmi R, Symington E, Escobar M, Gomez E, Kruse-Jarres R, Kotowski A, Quon D, Wang M, Wheeler A, Sawyer E, Verweij S, Colletta V, Bajma N, Gut R, Miesbach W. First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies. Blood 2020, 136: lba-6. DOI: 10.1182/blood-2020-143560.Peer-Reviewed Original ResearchAdeno-associated virus serotype 5Entity's Board of DirectorsEtranacogene dezaparvovecInvestigational gene therapyCSL BehringHemophilia BAdverse eventsPersonal feesGene therapyFrequent treatment-related adverse eventsClinical studiesPre-existing neutralizing antibodiesTreatment-related adverse eventsLead-InGene therapy clinical studiesPre-existing NAbsAnnualized bleeding rateGene therapy trialsInfusion-related reactionsPhase 2b studyPhase 3 studyLead-in periodUse of corticosteroidsInfluenza-like illnessLiver-specific promoter
2019
Conversion of a Conference Room into a Low-Acuity Inpatient Medical Unit: A Creative Response to Influenza-Related Surge
Fogerty RL, Cabie M, Doyle D, Brien P, Beley P, Jansen L, Stump L, Gaffney J, Ferencz KW, Lourenco C, Cushing W, Williams E, Marseglia J, Martinello RA, Morris V. Conversion of a Conference Room into a Low-Acuity Inpatient Medical Unit: A Creative Response to Influenza-Related Surge. The Joint Commission Journal On Quality And Patient Safety 2019, 45: 524-529. PMID: 31164262, DOI: 10.1016/j.jcjq.2019.02.004.Peer-Reviewed Original ResearchConceptsInfluenza-like illnessInpatient acute careEmergency department careAcademic medical centerInpatient medical unitsNumber of inpatientsED lengthInfluenza seasonED patientsAcute careInpatient admissionsInfection preventionHospital careMedical CenterInpatient unitMedical unitsValid optionClinical unitsCareAdmissionDisaster planClinical environmentNonclinical areasPatientsStay
2018
Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011–2015 - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC
Kajon AE, Lamson DM, Bair CR, Lu X, Landry ML, Menegus M, Erdman DD, St. George K. Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011–2015 - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2018, 24: 201-209. PMID: 29350143, PMCID: PMC5782899, DOI: 10.3201/eid2402.171407.Peer-Reviewed Original ResearchConceptsAcute respiratory diseaseCivilian adultsInfectious Diseases journal - CDCUS military recruitsLong-term care facilitiesInfluenza-like illnessAdenovirus type 4Respiratory infectionsHuman adenovirus type 4Vaccination protocolsCancer patientsHAdV-4Respiratory diseasePhysician's officeCare facilitiesNursing homesMilitary recruitsVaccine strainYoung adultsType 4Causative agentAdultsLike variantsMilitary settingsDetailed molecular characterization
2016
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France
Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O, Group T, Seddik K, Lesieur Z, Bonmarin I, Loulergue P, Bodilis H, Servera-Miyalou M, Sadler I, Momcilovic S, Kanaan R, Coolent N, Boun K, Blanche P, Charpentier J, Daviaud F, Mongardon N, Bretagnol A, Claessens Y, Rozenberg F, Yazdanpanah Y, Burdet C, Harent S, Lachatre M, Rioux C, Bleibtreu A, Casalino E, Choquet C, Leleu A, Belghalem K, Colosi L, Ranaivoson M, Verry V, Pereira L, Dupeyrat E, Bernard J, Emeyrat N, Chavance P, Debit A, Aubier M, Pradere P, Justet A, Mal H, Brugiere O, Papo T, Goulenok T, Boisseau M, Jouenne R, Alexandra J, Raynaud-Simon A, Lilamand M, Cloppet-Fontaine A, Becheur K, Pelletier A, Fidouh N, Ralaimazava P, Beaumale F, Costa Y, Munier E, Betend F, Amour S, Loeffert S, Francourt K, Merle C, Letois F, Géraud P, Driss V, Noslier S, Ray M, Sebbane M, Konaté A, Bourdin A, Klouche K, Léglise M, Couve-Deacon E, Fruit D, Fenerol C, Vallejo C, Jouneau S, Lainé F, Thébault E, Fillatre P, Le Pape C, Beuzit L, Chau F, Carrat F, Chau F, Goderel I. Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clinical Microbiology And Infection 2016, 23: 253-259. PMID: 27903461, PMCID: PMC7128342, DOI: 10.1016/j.cmi.2016.11.014.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolComorbidityDiagnosis, DifferentialFemaleFranceHospital MortalityHospitalizationHumansInfantInfluenza, HumanIntensive Care UnitsMaleMiddle AgedOdds RatioPatient Outcome AssessmentRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanRisk FactorsSeasonsYoung AdultConceptsRespiratory syncytial virus infectionInfluenza-like illnessRespiratory syncytial virusImmunosuppressive treatmentRisk factorsCause of influenza-like illnessVirus infectionRespiratory syncytial virus detectionInfluenza virus circulationConsecutive influenza seasonsInfluenza virus infectionIn-hospital mortality rateIntensive care unitInfluenza seasonInfluenza virusRespiratory failureAntiviral therapySevere complicationsClinical characteristicsInfrequent causeMulticentre studyRespiratory virusesSyncytial virusMedian lengthSpecific immunityInfluenza-like illness in an urban community of Salvador, Brazil: incidence, seasonality and risk factors
Oliveira CR, Costa GSR, Paploski IAD, Kikuti M, Kasper AM, Silva MMO, Tavares AS, Cruz JS, Queiroz TL, Lima HCAV, Calcagno J, Reis MG, Weinberger DM, Shapiro ED, Ko AI, Ribeiro GS. Influenza-like illness in an urban community of Salvador, Brazil: incidence, seasonality and risk factors. BMC Infectious Diseases 2016, 16: 125. PMID: 26975185, PMCID: PMC4791800, DOI: 10.1186/s12879-016-1456-8.Peer-Reviewed Original ResearchConceptsInfluenza-like illnessYears of ageAcute febrile illnessAnnual incidenceRisk of ILIChildren 5Year oldsIncidence of ILIMean annual incidenceEpidemiology of influenzaCommunity-based surveillanceNegative test resultsSeasonal influenza transmissionILI peakMethodsBetween 2009Febrile illnessSore throatRegression modelsDisease burdenRisk factorsSchool-aged childrenEmergency unitInfluenza transmissionSignificant burdenYoung school-age children
2011
Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC
Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev VV, Fish D, Krause PJ. Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2011, 17: 1816-1823. PMID: 22000350, PMCID: PMC3310649, DOI: 10.3201/eid1710.101474.Peer-Reviewed Original ResearchConceptsB. miyamotoi infectionMiyamotoi infectionInfectious Diseases journal - CDCBorrelia miyamotoiInfluenza-like illnessB. burgdorferi infectionFever spirochete Borrelia miyamotoiDisease-like symptomsFebrile illnessI. ricinus ticksErythema migransClinical manifestationsIxodid tick vectorsBurgdorferi infectionI. scapularis ticksIxodes persulcatus ticksInfectionRicinus ticksScapularis ticksB. burgdorferiB. gariniiFeverWidespread prevalenceIllnessMiyamotoi
2010
Household Transmission of 2009 Influenza A (H1N1) Virus after a School-Based Outbreak in New York City, April–May 2009
France AM, Jackson M, Schrag S, Lynch M, Zimmerman C, Biggerstaff M, Hadler J. Household Transmission of 2009 Influenza A (H1N1) Virus after a School-Based Outbreak in New York City, April–May 2009. The Journal Of Infectious Diseases 2010, 201: 984-992. PMID: 20187740, DOI: 10.1086/651145.Peer-Reviewed Original ResearchConceptsInfluenza-like illnessIndex case patientsInfluenza A virusesHousehold contactsCase patientsHousehold transmissionRisk of ILIPandemic influenza A (H1N1) virusA virusDays of onsetPercent of casesYears of ageExtent of transmissionAntiviral prophylaxisPH1N1 transmissionRisk factorsAdditional protective factorsHigh riskMultivariate analysisOlder ageProtective factorsIllnessIll studentsPatientsContact group
2003
Economic Costs of Influenza-Related Work Absenteeism
Akazawa M, Sindelar JL, Paltiel AD. Economic Costs of Influenza-Related Work Absenteeism. Value In Health 2003, 6: 107-115. PMID: 12641861, DOI: 10.1046/j.1524-4733.2003.00209.x.Peer-Reviewed Original ResearchConceptsNet benefitEconomic costsMedical Expenditure Panel Survey Household ComponentMean productivity costsAverage work lossDollar termsUS dollarsEmployment dataProductivity impactEconomic attractivenessNumber of workdaysWorking-age peopleHousehold ComponentProductivity costsWorker productivityWorker absenteeismEmployment factorsSimple frameworkInfluenza-like illnessDecision analysisReduced absenteeismCostBaseline analysisInfluenza vaccinationTerms of absence
1995
Infection with a Babesia-Like Organism in Northern California
Persing D, Herwaldt B, Glaser C, Lane R, Thomford J, Mathiesen D, Krause P, Phillip D, Conrad P. Infection with a Babesia-Like Organism in Northern California. New England Journal Of Medicine 1995, 332: 298-303. PMID: 7816065, DOI: 10.1056/nejm199502023320504.Peer-Reviewed Original ResearchConceptsB. microti antigenIndirect immunofluorescent antibody testingImmunofluorescent antibody testingInfluenza-like illnessHodgkin's diseaseSerologic testingAsymptomatic infectionClinical spectrumSeroprevalence ratesPolymerase chain reactionPatientsFatal diseaseProtozoal parasitesInfectionBabesia microtiHuman babesiosisBabesia antigensDiseaseGenetic sequence analysisChain reactionCanine pathogensAntigenB. divergensGenus Babesia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply